|
US3686412A
(en)
|
1965-03-25 |
1972-08-22 |
Colin Fitzmaurice |
Compositions containing bis-chromonyl compounds for inhibiting antigen-antibody reactions
|
|
GB1144905A
(en)
|
1965-03-25 |
1969-03-12 |
Fisons Pharmaceuticals Ltd |
Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
|
|
US3957965A
(en)
|
1967-08-08 |
1976-05-18 |
Fisons Limited |
Sodium chromoglycate inhalation medicament
|
|
GB1242211A
(en)
|
1967-08-08 |
1971-08-11 |
Fisons Pharmaceuticals Ltd |
Pharmaceutical composition
|
|
GB1257162A
(enExample)
|
1968-02-16 |
1971-12-15 |
|
|
|
US4405598A
(en)
|
1976-01-30 |
1983-09-20 |
Fisons, Limited |
Composition for treating asthma
|
|
DE3104294A1
(de)
|
1981-02-07 |
1982-08-19 |
Hoechst Ag, 6000 Frankfurt |
Substituierte diazaspirodecane, ihre herstellung, ihre verwendung als stabilisatoren fuer organische polymere, sowie die so stabilisierten polymeren
|
|
US4429545A
(en)
|
1981-08-03 |
1984-02-07 |
Ocean & Atmospheric Science, Inc. |
Solar heating system
|
|
BE897058A
(fr)
|
1982-06-25 |
1983-12-16 |
Sandoz Sa |
Utilisation d'un derive du spiro-succinimide dans le traitement de la demence du type alzheimer
|
|
US4996296A
(en)
|
1983-07-27 |
1991-02-26 |
Yeda Research & Development Co., Ltd. |
Cromolyn binding protein in highly purifed form, and methods for the isolation thereof
|
|
US5231170A
(en)
|
1986-08-27 |
1993-07-27 |
Paul Averback |
Antibodies to dense microspheres
|
|
US4919915A
(en)
|
1987-03-03 |
1990-04-24 |
Paul Averback |
Method for detecting the ability to prevent red-to-green congophilic birefringence
|
|
EP0470154B1
(en)
|
1989-04-28 |
1996-06-05 |
Riker Laboratories, Inc. |
Dry powder inhalation device
|
|
US5376386A
(en)
|
1990-01-24 |
1994-12-27 |
British Technology Group Limited |
Aerosol carriers
|
|
DE4405387A1
(de)
|
1994-02-19 |
1995-08-24 |
Hoechst Ag |
Verfahren zur Herstellung von Polyalkyl-1-oxa-diazaspirodecan-Verbindungen
|
|
US6168776B1
(en)
|
1994-07-19 |
2001-01-02 |
University Of Pittsburgh |
Alkyl, alkenyl and alkynyl Chrysamine G derivatives for the antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
|
|
CA2174583A1
(en)
|
1995-05-05 |
1996-11-06 |
Alexander Chucholowski |
Sulfuric acid esters of sugar alcohols
|
|
US6026809A
(en)
|
1996-01-25 |
2000-02-22 |
Microdose Technologies, Inc. |
Inhalation device
|
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
|
DE69813853T3
(de)
|
1997-09-29 |
2011-05-12 |
Novartis Ag |
Perforierte mikroteilchen und deren verwendung
|
|
US5904937A
(en)
|
1997-10-03 |
1999-05-18 |
Fmc Corporation |
Taste masked pharmaceutical compositions
|
|
TWI239847B
(en)
|
1997-12-02 |
2005-09-21 |
Elan Pharm Inc |
N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
|
|
CN1623607B
(zh)
|
1998-06-12 |
2011-03-30 |
微量技术公司 |
用于从容器输送粉状药物的空气吸入装置
|
|
US6197963B1
(en)
|
1998-08-13 |
2001-03-06 |
The Trustees Of The University Of Pennsylvania |
Non-peptide peptidomimetics
|
|
DK1283036T3
(da)
|
1998-11-13 |
2008-03-25 |
Jagotec Ag |
Törpulver til inhalation
|
|
KR100437105B1
(ko)
|
1998-12-24 |
2004-06-23 |
얀센 파마슈티카 엔.브이. |
방출 조절형 갈란타민 조성물
|
|
JP2001151673A
(ja)
|
1999-09-06 |
2001-06-05 |
Nikken Chem Co Ltd |
吸入用粉末製剤の製造方法
|
|
US20020107173A1
(en)
|
1999-11-04 |
2002-08-08 |
Lawrence Friedhoff |
Method of treating amyloid beta precursor disorders
|
|
US20020009491A1
(en)
|
2000-02-14 |
2002-01-24 |
Rothbard Jonathan B. |
Compositions and methods for enhancing drug delivery across biological membranes and tissues
|
|
US20030086938A1
(en)
|
2000-02-21 |
2003-05-08 |
Jensen Martin Roland |
Novel methods for down-regulation of amyloid
|
|
AU5702201A
(en)
|
2000-04-13 |
2001-10-30 |
Mayo Foundation |
Abeta<sub>42</sub> lowering agents
|
|
US20080021085A1
(en)
|
2000-04-13 |
2008-01-24 |
Mayo Foundation For Medical Education And Research |
Method of reducing abeta42 and treating diseases
|
|
PE20011227A1
(es)
|
2000-04-17 |
2002-01-07 |
Chiesi Farma Spa |
Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
|
|
MY120279A
(en)
|
2000-05-26 |
2005-09-30 |
Pharmacia Corp |
Use of a celecoxib composition for fast pain relief
|
|
US20020016359A1
(en)
|
2000-06-29 |
2002-02-07 |
Hellberg Mark R. |
Compositions and methods of treating neurodegenerative diseases
|
|
US8519005B2
(en)
|
2000-07-27 |
2013-08-27 |
Thomas N. Thomas |
Compositions and methods to prevent toxicity of antiinflammatory agents and enhance their efficacy
|
|
FR2815030A1
(fr)
|
2000-10-05 |
2002-04-12 |
Lipha |
Derives nitroso de la diphenylamine, compositions pharmaceutiques les contenant et leur utilisation pour la preparation de medicaments
|
|
US6511960B2
(en)
|
2001-01-05 |
2003-01-28 |
Alphamed Pharmaceuticals Corp |
Cromolyn for eye and ear infections
|
|
ES2274973T3
(es)
|
2001-04-23 |
2007-06-01 |
The Trustees Of The University Of Pennsylvania |
Inhibidores de la agregacion de placas amiloides y agentes de obtencion de imagenes diagnosticas.
|
|
JP5196701B2
(ja)
|
2001-11-29 |
2013-05-15 |
エミスフィアー テクノロジーズ インコーポレイテッド |
クロモリンナトリウムの経口投与用製剤
|
|
AU2003228963B2
(en)
|
2002-05-10 |
2009-01-22 |
Oriel Therapeutics, Inc. |
Dry powder inhalers
|
|
EP1601379A1
(en)
*
|
2003-02-13 |
2005-12-07 |
Licentia OY |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of a patient subjected to thrombolyses
|
|
WO2004071531A1
(en)
|
2003-02-13 |
2004-08-26 |
Licentia Oy |
Use of a mast cell activation or degranulation blocking agent in the manufacture of a medicament for the treatment of cerebral ischemia
|
|
US20040223918A1
(en)
|
2003-05-07 |
2004-11-11 |
Chrysalis Technologies Incorporated |
Aerosolization of cromolyn sodium using a capillary aerosol generator
|
|
GB0321607D0
(en)
|
2003-09-15 |
2003-10-15 |
Vectura Ltd |
Manufacture of pharmaceutical compositions
|
|
JP2007509941A
(ja)
|
2003-10-28 |
2007-04-19 |
グラクソ グループ リミテッド |
ラクトース無水物を用いる吸入医薬製剤およびその投与方法
|
|
GB0326632D0
(en)
|
2003-11-14 |
2003-12-17 |
Jagotec Ag |
Dry powder formulations
|
|
DE10355559A1
(de)
|
2003-11-21 |
2005-06-23 |
Orthogen Ag |
Transskin
|
|
US8088935B2
(en)
|
2003-12-23 |
2012-01-03 |
Ironwood Pharmaceuticals, Inc. |
Compounds and methods for the treatment of asthma
|
|
US20070093457A1
(en)
|
2004-02-11 |
2007-04-26 |
Nadir Arber |
Compositions for treatment of cancer and inflammation with curcumin and at least one nsaid
|
|
US20050182044A1
(en)
|
2004-02-17 |
2005-08-18 |
Bruinsma Gosse B. |
Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
|
|
US20070293538A1
(en)
|
2004-04-13 |
2007-12-20 |
Myriad Genetics, Incorporated |
Pharmaceutical Composition And Methods For Treating Neurodegenerative Disorders
|
|
PL2708225T3
(pl)
|
2004-04-23 |
2019-07-31 |
Cydex Pharmaceuticals, Inc. |
Formulacja DPI zawierająca eter sulfoalkilowy cyklodekstryny
|
|
KR101414810B1
(ko)
|
2004-08-30 |
2014-07-18 |
주식회사 유스팜인터내셔널 |
국소 허혈 모델에서의 가용화 ｕｄｃａ의 신경보호 효과
|
|
CA2585471A1
(en)
*
|
2004-11-01 |
2006-05-11 |
Seo Hong Yoo |
Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
|
|
GB0426146D0
(en)
|
2004-11-29 |
2004-12-29 |
Bioxell Spa |
Therapeutic peptides and method
|
|
WO2006116369A2
(en)
|
2005-04-22 |
2006-11-02 |
Genentech, Inc. |
Method for treating dementia or alzheimer's disease with a cd20 antibody
|
|
EP1893576A4
(en)
|
2005-05-27 |
2010-03-17 |
Univ Kingston |
TREATMENT OF PROTEIN DISORDERING
|
|
JP2009519972A
(ja)
|
2005-12-15 |
2009-05-21 |
アキュスフィア， インコーポレイテッド |
粒子ベースの経肺投与または経鼻投与用製薬の製造方法
|
|
US8263645B2
(en)
|
2006-02-03 |
2012-09-11 |
Pari Pharma Gmbh |
Disodium cromoglycate compositions and methods for administering same
|
|
AR059356A1
(es)
|
2006-02-14 |
2008-03-26 |
Astrazeneca Ab |
Nuevos radioligandos
|
|
JP2009536918A
(ja)
|
2006-03-06 |
2009-10-22 |
ファイザー株式会社 |
スルホニルベンゾイミダゾール誘導体
|
|
EP1996175A4
(en)
|
2006-03-09 |
2009-06-10 |
Waratah Pharmaceuticals Inc |
CYCLOHEXAN POLYALKOHOL FORMULATION FOR THE TREATMENT OF PROTEIN AGGREGATION DISORDERS
|
|
US7700616B2
(en)
|
2006-05-08 |
2010-04-20 |
Molecular Neuroimaging, Llc. |
Compounds and amyloid probes thereof for therapeutic and imaging uses
|
|
US8445437B2
(en)
|
2006-07-27 |
2013-05-21 |
The Brigham And Women's Hospital, Inc. |
Treatment and prevention of cardiovascular disease using mast cell stabilizers
|
|
WO2008034244A1
(en)
|
2006-09-21 |
2008-03-27 |
Waratah Pharmaceuticals Inc. |
The combination of a cyclohexanehexol and a nsaid for the treatment of neurodegenerative diseases
|
|
WO2008061373A1
(en)
|
2006-11-24 |
2008-05-29 |
Waratah Pharmaceuticals Inc. |
Combination treatments for alzheimer's disease and similar diseases
|
|
WO2008128981A1
(en)
|
2007-04-18 |
2008-10-30 |
Probiodrug Ag |
Nitrovinyl-diamine derivatives as glutaminyl cyclase inhibitors
|
|
EP2146746A4
(en)
|
2007-04-18 |
2011-03-23 |
Janssen Alzheimer Immunotherap |
PREVENTIVE AND TREATING ZEREBRALER AMYLOID ANGIOPATHY
|
|
US7858803B2
(en)
|
2007-04-27 |
2010-12-28 |
The General Hospital Corporation |
Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders
|
|
CA2693771A1
(en)
|
2007-07-13 |
2009-01-22 |
Abbott Biotechnology Ltd. |
Methods and compositions for pulmonary administration of a tnf.alpha. inhibitor
|
|
GB0714134D0
(en)
|
2007-07-19 |
2007-08-29 |
Norton Healthcare Ltd |
Dry-powder medicament
|
|
SI2182983T1
(sl)
|
2007-07-27 |
2014-09-30 |
Janssen Alzheimer Immunotherapy |
Zdravljenje amiloidogenih bolezni s humaniziranimi protitelesi proti abeta
|
|
JO3076B1
(ar)
|
2007-10-17 |
2017-03-15 |
Janssen Alzheimer Immunotherap |
نظم العلاج المناعي المعتمد على حالة apoe
|
|
US8450466B2
(en)
|
2008-03-21 |
2013-05-28 |
The General Hosptial Corporation |
Compounds and compositions for the detection and treatment of Alzheimer's disease and related disorders
|
|
CN102065858B
(zh)
|
2008-04-29 |
2014-07-02 |
法奈科斯公司 |
使用唑尼沙胺和阿坎酸治疗阿尔茨海默病和相关病症的组合组合物
|
|
KR20110117146A
(ko)
|
2009-01-22 |
2011-10-26 |
라퀄리아 파마 인코포레이티드 |
Ｃｂ2 수용체 효능활성이 있는 ｎ-치환 포화 헤테로사이클릭 술폰 화합물
|
|
US8381454B1
(en)
|
2009-01-23 |
2013-02-26 |
Markus R. Robinson |
Segmented, elongated, expandable, 4-season, double-walled, low-cost, rigid extruded plastic panel structures
|
|
US9925282B2
(en)
|
2009-01-29 |
2018-03-27 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
CA2751125C
(en)
*
|
2009-01-29 |
2017-06-20 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
TW201613969A
(en)
|
2009-03-05 |
2016-04-16 |
Abbvie Inc |
IL-17 binding proteins
|
|
EP2406260A1
(en)
|
2009-03-11 |
2012-01-18 |
Plexxikon, Inc. |
Pyrrolo [2, 3-b]pyridine derivatives for the inhibition of raf kinases
|
|
JP2012520883A
(ja)
|
2009-03-16 |
2012-09-10 |
アイピントゥル，エルエルシー |
アルツハイマー病及び骨粗鬆症の治療並びに老化の軽減
|
|
ES2457442T3
(es)
|
2009-05-08 |
2014-04-25 |
Pari Pharma Gmbh |
Formulaciones farmacéuticas concentradas estabilizadoras de los mastocitos
|
|
WO2011017030A2
(en)
*
|
2009-08-06 |
2011-02-10 |
Neuraltus Pharmaceuticals, Inc. |
Treatment of macrophage-related disorders
|
|
EP3378856B1
(en)
|
2009-09-24 |
2020-12-02 |
WisTa Laboratories Ltd. |
Crystalline methylthioninium chloride hydrates
|
|
EP2322163A1
(en)
|
2009-11-03 |
2011-05-18 |
Pharnext |
New therapeutics approaches for treating alzheimer disease
|
|
WO2011057199A1
(en)
|
2009-11-06 |
2011-05-12 |
Adenios, Inc. |
Compositions for treating cns disorders
|
|
NZ600123A
(en)
|
2009-11-30 |
2015-04-24 |
Aptalis Pharmatech Inc |
Compressible-coated pharmaceutical compositions and tablets and methods of manufacture
|
|
US20110256064A1
(en)
|
2010-04-16 |
2011-10-20 |
Ac Immune, S.A. |
Novel Compounds for the Treatment of Diseases Associated with Amyloid or Amyloid-like Proteins
|
|
WO2011136754A1
(en)
|
2010-04-26 |
2011-11-03 |
Mahmut Bilgic |
A medicament developed for the treatment of respiratory diseases
|
|
JP2013533320A
(ja)
*
|
2010-08-12 |
2013-08-22 |
レバレジオ コーポレイション |
タウオパチーを治療するための組成物および方法
|
|
CN103298470B
(zh)
|
2010-09-30 |
2015-06-17 |
奇斯药制品公司 |
硬脂酸镁在吸入用干粉制剂中的用途
|
|
US20120121656A1
(en)
|
2010-11-15 |
2012-05-17 |
Revalesio Corporation |
Methods and compositions for protecting against neurotoxicity of a neurotoxic agent, and improving motor coordination associated with a neurodegenerative condition or disease
|
|
CA2827027C
(en)
|
2011-02-11 |
2019-06-04 |
Wista Laboratories Ltd. |
Phenothiazine diaminium salts and their use
|
|
SG11201406142XA
(en)
|
2012-03-27 |
2014-10-30 |
Univ Duke |
Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
|
|
EP2854781A4
(en)
|
2012-05-25 |
2016-04-13 |
Xlear Inc |
XYLITOL-BASED ANTIMUKOSAL COMPOSITIONS AND ASSOCIATED METHODS AND COMPOSITIONS
|
|
CA2883130A1
(en)
*
|
2012-08-31 |
2014-03-06 |
The General Hospital Corporation |
Biotin complexes for treatment and diagnosis of alzheimer's disease
|
|
CN104981242A
(zh)
|
2012-10-23 |
2015-10-14 |
帝人制药株式会社 |
肿瘤溶解综合征的治疗药和预防药
|
|
US10058530B2
(en)
|
2012-10-25 |
2018-08-28 |
The General Hospital Corporation |
Combination therapies for the treatment of Alzheimer's disease and related disorders
|
|
US9855276B2
(en)
|
2012-10-25 |
2018-01-02 |
The General Hospital Corporation |
Combination therapies for the treatment of Alzheimer's disease and related disorders
|
|
US10525005B2
(en)
|
2013-05-23 |
2020-01-07 |
The General Hospital Corporation |
Cromolyn compositions and methods thereof
|
|
WO2015002703A1
(en)
*
|
2013-05-23 |
2015-01-08 |
Aztherapies, Inc |
Methods for delivering cromolyn
|
|
CN104288168B
(zh)
*
|
2013-07-17 |
2017-08-18 |
吉林敖东洮南药业股份有限公司 |
延龄草苷在制备用于治疗和/或预防小胶质细胞介导的疾病的药物中的用途
|
|
AU2014340182B2
(en)
|
2013-10-22 |
2019-05-23 |
The General Hospital Corporation |
Cromolyn derivatives and related methods of imaging and treatment
|
|
CN106535889A
(zh)
*
|
2014-02-10 |
2017-03-22 |
帕塔拉制药有限责任公司 |
用于治疗肺疾病的肥大细胞稳定剂
|
|
CA2938994A1
(en)
|
2014-02-10 |
2015-08-13 |
Patara Pharma, LLC |
Inhalable formulations of sodium cromolyn with improved bioavailability
|
|
BR112017010440A2
(pt)
|
2014-11-21 |
2017-12-26 |
Biohaven Pharm Holding Co Ltd |
administração sublingual de riluzol
|
|
WO2016196401A1
(en)
|
2015-05-29 |
2016-12-08 |
The Texas A&M University System |
Antimicrobial and anti-inflammatory compositions
|
|
EP3331522A1
(en)
|
2015-08-07 |
2018-06-13 |
Patara Pharma LLC |
Methods for the treatment of mast cell related disorders with mast cell stabilizers
|
|
US10265296B2
(en)
|
2015-08-07 |
2019-04-23 |
Respivant Sciences Gmbh |
Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
|
|
US20180311236A1
(en)
*
|
2015-10-28 |
2018-11-01 |
Ab Science |
Use of masitinib and other mast cell inhibitors for treatment of parkinson's disease
|
|
CN108472393A
(zh)
*
|
2015-11-19 |
2018-08-31 |
阿尔茨治疗方法公司 |
用于治疗阿尔茨海默病和有关病症的方法
|
|
AU2016359674A1
(en)
*
|
2015-11-23 |
2018-06-14 |
The General Hospital Corporation |
Compositions and methods for treating ischemic stroke
|
|
BR112018069515A2
(pt)
*
|
2016-03-25 |
2019-04-16 |
Ab Science |
uso de masitinibe para tratamento de uma subpopulação de pacientes com esclerose lateral amiotrófica
|
|
EP3506894B1
(en)
|
2016-08-31 |
2023-08-23 |
The General Hospital Corporation |
Macrophages/microglia in neuro-inflammation associated with neurodegenerative diseases
|
|
JP2019529541A
(ja)
|
2016-09-08 |
2019-10-17 |
エマーゴ セラピューティクス，インク． |
高サイトカイン血症及びウィルス感染の処置の為の肥満細胞安定剤
|
|
WO2019017995A1
(en)
|
2017-07-20 |
2019-01-24 |
Aztherapies, Inc. |
FORMULATIONS OF CROMOLYNE SODIUM POWDER AND IBUPROFEN
|
|
CN108164409B
(zh)
|
2018-01-24 |
2021-06-18 |
温州医科大学 |
一种2-亚苄基-1-茚酮类似物及应用
|
|
CA3096545A1
(en)
|
2018-04-09 |
2019-10-17 |
The General Hospital Corporation |
Combination therapies for the treatment of amyotropic lateral sclerosis and related disorders
|
|
CN108403708B
(zh)
|
2018-05-22 |
2019-06-14 |
滨州医学院 |
秦皮苷在制备预防或治疗急性呼吸窘迫综合征药物中的应用
|
|
JP2021529771A
(ja)
|
2018-07-02 |
2021-11-04 |
ザ ジェネラル ホスピタル コーポレイション |
クロモリンナトリウムおよびα−ラクトースの粉末製剤
|
|
CA3111217A1
(en)
|
2018-09-05 |
2020-03-12 |
The General Hospital Corporation |
Methods of treating cytokine release syndrome
|
|
US12383528B2
(en)
|
2018-12-10 |
2025-08-12 |
The General Hospital Corporation |
Cromolyn esters and uses thereof
|
|
JP2023520580A
(ja)
|
2020-04-06 |
2023-05-17 |
ザ ジェネラル ホスピタル コーポレイション |
コロナウイルス誘発炎症状態の処置方法
|
|
US20230226017A1
(en)
|
2020-06-04 |
2023-07-20 |
The General Hospital Corporation |
Methods of treating a coronavirus infection
|
|
WO2022146914A1
(en)
|
2020-12-28 |
2022-07-07 |
The General Hospital Corporation |
Cromolyn derivatives and uses thereof
|